Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind phase III trial of remifentanil vs fentanyl for analgesia in ICU patients on mechanical ventilation
CTR20210946Phase 3Completed
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of remifentanil in pain, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started May 2021; status: completed.
02
Drugs
remifentanil
03
Conditions
pain
Beyond the preview
Go deeper on CTR20210946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210946.